Logo Lanfrica
  • Accueil
  • Atlas
  • Analyses
  • Documentation
  • Sign in

© 2026 Lanfrica. Tous droits réservés. Tous les droits d'auteur des ressources affichées sur le site Web Lanfrica appartiennent aux détenteurs de droits d'auteur d'origine, sauf indication contraire explicite.

uthmanolanase/Analysis-of-Drug-Resistant_Tuberculosis-in-Nigeria

Domaine:

healthcare

Type de record:

paper
Créateur:
uth
Hôte:
Independent R-based analysis of MDR/RR-TB trends in Nigeria (2015–2023). # 📊 Analysis of Drug-Resistant Tuberculosis in Nigeria ### 🧠 Author: Uthman Al-Ameen Olalekan *MPH, University of Ibadan, Nigeria* *PhD Applicant in Epidemiology* ## 📌 Overview This project presents an independent R-based analysis of the burden and trends of multidrug/rifampicin-resistant tuberculosis (MDR/RR-TB) in Nigeria from 2015 to 2023. Using publicly available WHO Global TB surveillance data, the analysis includes descriptive statistics, data visualization, correlation analysis, and linear regression to explore patterns and predictors of treatment initiation. This manuscript is currently under review at BMC Infectious Diseases (Springer Nature). > 📄 **Preprint Notice:** > This study was previously shared as a preprint on *Research Square*: > **Uthman Olalekan Al-Ameen (2025).** *Assessment of the Tuberculosis Care Cascade in Nigeria: A 9-Year Analysis of MDR/RR- TB Detection and Treatment (2015–2023).* > 🔗 DOI: doi.org > 📜 *This is a preprint and is currently under peer review.* > Licensed under a **CC BY 4.0 License**. > This repository provides all code, datasets, and outputs to promote transparency and reproducibility ## 🧪 Objective To examine the patterns and trends of **drug-resistant tuberculosis (TB) in Nigeria (2015–2023)**, with particular focus on: - 📊 Incidence of Drug-Resistant TB - ✅ Treatment Success Rates - 🔄 Resistance Trends across MDR-TB and RR-TB cases ## Methods - Descriptive statistics to examine temporal patterns - Line and scatter plots using `ggplot2` for visual representation - Correlation analysis to assess relationships between case estimates and treatment data - Linear regression to identify potential predictors of treatment coverage ## Tools & Packages - R Markdown (for reproducible reporting) - ggplot2, dplyr, readr (for data wrangling and visualization) - flextable, officer (for automated reporting) ## 📂 Data Sources - World Health Organization (WHO) ## 📈 Sample Visualizations …

Visit

github.com

Tags

analysis-of-drug-resistant-tuberculosis-in-nigeria

Similaires

Analysis of drug abuse in Nigeria: New insights, innovative surveillance, and promising interventionsA Socio-Psychological Analysis of Doping and Drug Abuse Among University Athletes in NigeriaEvaluation of potential drug–drug interactions among patients with chronic kidney disease in northeastern NigeriaTackling the challenges of antimalarial drug resistance in NigeriaCLINICALLY SIGNIFICANT DRUG-DRUG INTERACTION IN A LARGE ANTIRETROVIRAL TREATMENT CENTRE IN LAGOS, NIGERIAIn silico prediction of potential antimalarial drug candidates through genomic analysis

Analysis of drug abuse in Nigeria: New insights, innovative surveillance, and promising interventions

Drug abuse remains a pressing public health concern in Nigeria, with increasing prevalence among ado

A Socio-Psychological Analysis of Doping and Drug Abuse Among University Athletes in Nigeria

Abstract Doping and drug abuse have quietly become one of the most pressing, yet under-discussed, c

Evaluation of potential drug–drug interactions among patients with chronic kidney disease in northeastern Nigeria

Background: Potential drug–drug interactions (pDDIs) may not manifest clinically in patients who are

Tackling the challenges of antimalarial drug resistance in Nigeria

This Community Based Master's Project for the Degree of Master of Public Health is a comprehensive w

CLINICALLY SIGNIFICANT DRUG-DRUG INTERACTION IN A LARGE ANTIRETROVIRAL TREATMENT CENTRE IN LAGOS, NIGERIA

Background An important cause of treatment failure to antiretroviral therapy (AR

In silico prediction of potential antimalarial drug candidates through genomic analysis

Introduction: Plasmodium falciparum malaria, an infectious  disease, kills lot of